ANI PHARMACEUTICALS INC (ANIP)
Pharmaceutical Preparations
Latest Price
$70.19
TTM P/E
15.26
Normalized P/E
2064.41
Div Yield
--
Book Value
28.39
P/B Ratio
2.47
Valuation metrics
adjust assumptions →EPS: $3.32
Book value / share: $24.04
Formula: √(22.5 × EPS × BVPS)
Graham Number
$42.38
40% downside
Base FCF: $79M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$14.67
79% downside
EPS: $3.32
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$49.80
29% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.96M | $244.0M | 13.98% | +211.2K | 2026-06-30 |
| Soleus Capital Management, L.P. | 867.8K | $71.0M | 4.10% | +47.5K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 838.2K | $69.0M | 3.96% | +15.2K | 2026-06-30 |
| STATE STREET CORP | 831.6K | $68.0M | 3.93% | +60.1K | 2026-06-30 |
| TANG CAPITAL MANAGEMENT LLC | 707.5K | $58.0M | 3.34% | -- | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 623.5K | $51.0M | 2.95% | +92.3K | 2026-06-30 |
| AMERICAN CENTURY COMPANIES INC | 574.5K | $47.0M | 2.72% | +382.9K | 2026-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 562.0K | $46.0M | 2.66% | -2.3K | 2026-06-30 |
| Global Alpha Capital Management Ltd. | 558.0K | $46.0M | 2.64% | +196.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 536.4K | $44.0M | 2.54% | +47.2K | 2026-06-30 |